Dedicated to Research Since 1993
  •  

    info@genesismarketinsights.com

In-vitro fertilization (IVF) Market By Types of cycle (Fresh Cycle (Non-Donor), Thawed IVF Cycle (Non-Donor), Donor Egg IVF Cycle) By Application (Fertility Clinics, Hospitals, Surgical Centers) - Global Size Analysis and Industry Forecast, 2018-2023.

 Healthcare and Pharmaceuticals

Report Overview

Global In-vitro fertilization (IVF) Market was valued at USD 507.98 Million in the year 2017. Global In-vitro fertilization (IVF) Market is further estimated to grow at a CAGR of 10.41 % from 2018 to reach USD 920 Million by the year 2023. North America region holds the highest market share in 2017 and Europe is considered as the fastest growing market in the forecasted period. At country level, developed markets U.S holds a substantial market share in 2017 and it is projected to grow at a gradual pace in the coming years.

OvaScience (U.S), EMD Serono, Inc. (U.S), Irvine Scientific (U.S), CooperSurgical, Inc. (U.S) and Vitrolife AB (Sweden) are some of the key players in the In-vitro fertilization (IVF) Market. Rising research and development expenses to address the changing demand of end users, similarly growth strategies such as acquisition, merger and expansion of the distribution network were few techniques adopted by most of the top players in the last 5 years.

Drivers:

            Declining fertility rate

            Increasing incidences of male and female infertility

Restraints:

            High Cost and Low Success Rate of the IVF Treatment

            Lack of regulatory framework

Opportunities:

            Availability of supportive government funding

            Fertility Tourism

Challenges:

            Reducing Efficacy of Infertility Treatment with Advancing Age

            Ethical considerations

The global in-vitro fertilization (IVF) market id segmented on the basis of types of cycle, by application and by region. On the basis of types of cycle the market is segmented as Fresh Cycle (Non-Donor), Thawed IVF Cycle (Non-Donor) and Donor Egg IVF Cycle of which Fresh Cycle (Non-Donor) segment is expected to hold the highest market share during the forecast period.

On the basis of application the market is segmented as Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes, in which Fertility Clinics holds the highest market share.

Key Benefits for Stakeholders

In-vitro fertilization (IVF) Manufacturers, Distributors and Retailers

Research and Consulting organization

Healthcare service providers & Vendors

Healthcare institutions (hospitals, clinics, cryobanks)

Research institutes

By Types of cycle

Fresh Cycle (Non-Donor)

Thawed IVF Cycle (Non-Donor)

Donor Egg IVF Cycle

By Application

Fertility Clinics

Hospitals

Surgical Centers

Clinical Research Institutes

By Region

North America

Europe

Asia-Pacific

RoW

Key Market Players

OvaScience      

EMD Serono, Inc.          

Irvine Scientific

CooperSurgical, Inc.

Vitrolife AB

Cook Medical, Inc.

Progyny, Inc.    

Genea Biomedx

Boston IVF

Kitazato Corporation

(Another brief information of 15 companies will be provided in report.)

Research Methodology:

Genesis Market Insights follows in-depth Research Methodology focused on reducing deviation in the collected data. GMI offers the most precise evaluations and projection for the market numbers. GMI engages following Market Engineering techniques –

  1.      Raw Market Data is collected and compared with the Existing in-house Data on a broad front.
  2.      Both Bottom-Up and Top-Down approaches are analyzed for segmenting and estimating measurable aspects of the market.
  3.      To avoid bias, we filter the collected data collected from authenticated sources.
  4.      GMI has a well proven Statistical Modeling System for estimates and forecasts.
  5.      Further, the report findings are validated with the Industry Expert Panel on face to face or telephonic interviews.
  6.      Panelists are approached from Leading Enterprises across the value chain including manufacturers, suppliers, technology providers, domain experts and buyers so as to validate a thorough and balanced market overview.

Detailed customization is also available for you. Further, if the report listed above does not meet with your key requirements. Our customized research report will analytically cover the required market information you need which will help you to plan your business decisions.

Table Of Content

1. Introduction

1.1 Market Vision

       1.1.1 Market Definition

       1.1.2 Market Scope

1.2 Limitations

1.3 Stakeholders

2. Research Methodology

2.1. Research Process

       2.1.1. Secondary Research

             2.1.1.1. Key Data from Secondary Research

       2.1.2. Primary Research

             2.1.2.1. Key Data from Primary Research

             2.1.2.2. Breakdowns of Primary Interviews

2.2. Market Size Estimation

       2.2.1. Bottoms-Up Approach

       2.2.2. Top-Down Approach

       2.2.3. Annual Revenue Process

2.3. Data Triangulation 

2.4. Research Assumptions 

       2.4.1. Assumption

3. Executive Summary

4. Market Overview

4.1. Introduction

4.2. Drivers

4.3. Restraints

4.4. Opportunities

4.5. Challenges

4.6. Regulations

4.7. Supply Chain/Value Chain Analysis

4.8. Patent & Standards

5. Industry Trends

5.1. Introduction

5.2. Porter’s Five Forces Analysis

       5.2.1. Threat of New Entrants

       5.2.2. Threat of Substitutes

       5.2.3. Bargaining Power of Buyers

       5.2.4. Bargaining Power of Suppliers

       5.2.5. Intensity of Competitive Rivalry

6. In-vitro fertilization (IVF) Market, By Types of cycle

6.1. Fresh Cycle (Non-Donor)

6.2 Thawed IVF Cycle (Non-Donor)

6.3 Donor Egg IVF Cycle

7. In-vitro fertilization (IVF) Market, By Application

7.1. Fertility Clinics

7.2 Hospitals

7.3 Surgical Centers

7.4 Clinical Research Institutes

8. Geographical Analysis

8.1. Introduction

8.2. North America

       8.2.1. U.S.

       8.2.2. Canada

       8.2.3. Mexico

8.3. Europe

       8.3.1. U.K.

       8.3.2. Germany

       8.3.3. Italy

       8.3.4. France

       8.3.5. RoE

8.4. Asia Pacific

       8.4.1. South Korea

       8.4.2. China

       8.4.3. Japan

       8.4.4. South Korea

       8.4.5. RoAPAC

8.5. RoW

       8.5.1. Latin America

       8.5.2. Middle East and Africa

9. Company Profiles

(Business Overview, Financial Overview, Product write Up, Recent Developments)

9.1. OvaScience

9.2 EMD Serono, Inc.     

9.3 Irvine Scientific

9.4 CooperSurgical, Inc.

9.5 Vitrolife AB

9.6 Cook Medical, Inc.

9.7 Progyny, Inc.          

9.8 Genea Biomedx

9.9 Boston IVF

9.10 Kitazato Corporation

 

(Another brief information of 15 companies will be provided in report.)

 

10. Competitive Analysis

10.1. Introduction

10.2. Market Positioning of Key Players

10.3 Competitive Strategies Adopted by Leading Players

        10.3.1. Investments & Expansions

        10.3.2. New Product Launches

        10.3.3. Mergers & Acquisitions

        10.3.4. Agreements, Joint Ventures, and Partnerships

11. Appendix

11.1. Questionnaire

11.2. Available Customizations 

11.3. Upcoming Events (Trade Fair, Exhibitions, Conferences)

 

List of Tables (59 Tables)

TABLE 1 IVF - Key market driver analysis
TABLE 2 IVF - Key market restraint analysis
TABLE 3 Cost variations for IVF treatment throughout different countries
TABLE 4 Comparison between fresh and frozen donor treatment (USA)
TABLE 5 Current Canadian Law on ART
TABLE 6 IVF- Key market driver analysis
TABLE 7 IVF -Key market restraint analysis
TABLE 8 North America IVF market, by region, 2017-2023 (USD Million)
TABLE 9 North America IVF market, by instruments, 2017-2023(USD Million)
TABLE 10 North America IVF market, by type, 2017-2023(USD Million)
TABLE 11 North America IVF market, by end use, 2017-2023(USD Million)
TABLE 12 U.S. IVF market, by instruments, 2017-2023(USD Million)
TABLE 13 U.S. IVF market, by type, 2017-2023(USD Million)
TABLE 14 U.S. IVF market, by end use, 2017-2023(USD Million)
TABLE 15 Canada IVF market, by instruments, 2017-2023(USD Million)
TABLE 16 Canada IVF market, by type, 2017-2023(USD Million)
TABLE 17 Canada IVF market, by end use, 2017-2023(USD Million)
TABLE 18 Europe IVF market, by region, 2017-2023(USD Million)
TABLE 19 Europe IVF market, by instruments, 2017-2023(USD Million)
TABLE 20 Europe IVF market, by type, 2017-2023(USD Million)
TABLE 21 Europe IVF market, by end use, 2017-2023(USD Million)
TABLE 22 UK IVF market, by instruments, 2017-2023(USD Million)
TABLE 23 UK IVF market, by type, 2017-2023(USD Million)
TABLE 24 UK IVF market, by end use, 2017-2023(USD Million)
TABLE 25 France IVF market, by instruments, 2017-2023(USD Million)
TABLE 26 France IVF market, by type, 2017-2023(USD Million)
TABLE 27 France IVF market, by end use, 2017-2023(USD Million)
TABLE 28 Germany IVF market, by instruments, 2017-2023(USD Million)
TABLE 29 Germany IVF market, by type, 2017-2023(USD Million)
TABLE 30 Germany IVF market, by end use, 2017-2023(USD Million)
TABLE 31 Asia Pacific IVF market, by region, 2017-2023(USD Million)
TABLE 32 Asia Pacific IVF market, by instruments, 2017-2023(USD Million)
TABLE 33 Asia Pacific IVF market, by type, 2017-2023(USD Million)
TABLE 34 Asia Pacific IVF market, by end use, 2017-2023(USD Million)
TABLE 35 India IVF market, by instruments, 2017-2023(USD Million)
TABLE 36 India IVF market, by type, 2017-2023(USD Million)
TABLE 37 India IVF market, by end use, 2017-2023(USD Million)
TABLE 38 China IVF market, by instruments, 2017-2023(USD Million)
TABLE 39 China IVF market, by type, 2017-2023(USD Million)
TABLE 40 China IVF market, by end use, 2017-2023(USD Million)
TABLE 41 Japan IVF market, by instruments, 2017-2023(USD Million)
TABLE 42 Japan IVF market, by type, 2017-2023(USD Million)
TABLE 43 Japan IVF market, by end use, 2017-2023(USD Million)
TABLE 44 Latin America IVF market, by region, 2017-2023(USD Million)
TABLE 45 Latin America IVF market, by instruments, 2017-2023(USD Million)
TABLE 46 Latin America IVF market, by type, 2017-2023(USD Million)
TABLE 47 Latin America IVF market, by end use, 2017-2023(USD Million)
TABLE 48 Brazil IVF market, by instruments, 2017-2023(USD Million)
TABLE 49 Brazil IVF market, by type, 2017-2023(USD Million)
TABLE 50 Brazil IVF market, by end use, 2017-2023(USD Million)
TABLE 51 Mexico IVF market, by instruments, 2017-2023(USD Million)
TABLE 50 Mexico IVF market, by type, 2017-2023(USD Million)
TABLE 52 Mexico IVF market, by end use, 2017-2023(USD Million)
TABLE 53 MEA IVF market, by region, 2017-2023(USD Million)
TABLE 54 MEA IVF market, by instruments, 2017-2023(USD Million)
TABLE 55 MEA IVF market, by type, 2017-2023(USD Million)
TABLE 56 MEA IVF market, by end use, 2017-2023(USD Million)
TABLE 57 South Africa IVF market, by instruments, 2017-2023(USD Million)
TABLE 58 South Africa IVF market, by type, 2017-2023(USD Million)
TABLE 59 South Africa IVF market, by end use, 2017-2023(USD Million)


List of Figures (60 Figures)

FIG. 1 Market research process
FIG. 2 Information procurement
FIG. 3 Primary research pattern
FIG. 4 Market research approaches
FIG. 5 Value Chain Based Sizing & Forecasting
FIG. 6 QFD modelling for market share assessment
FIG. 7 Market summary
FIG. 8 IVF: market segmentation
FIG. 9 IVF market revenue, (USD Million), 2017
FIG. 10 IVF: Market dynamics
FIG. 11 Female age-based chance of conception
FIG. 12 Key opportunities prioritized
FIG. 13 IVF Porter’s analysis
FIG. 14 IVF PESTEL analysis
FIG. 15 Global IVF market share, by instrument, 2017 & 2025
FIG. 16 Capital equipment market, 2017-2023(USD Million)
FIG. 17 Culture media market, 2017-2023(USD Million)
FIG. 18 IVF disposable devices market, 2017-2023(USD Million)
FIG. 19 Global IVF market share, by type, 2017 & 2025
FIG. 20 Fresh Donor market, 2017-2023(USD Million)
FIG. 21 Fresh Nondonor market, 2017-2023(USD Million)
FIG. 22 Frozen Donor market, 2017-2023(USD Million)
FIG. 23 Frozen Nondonor market, 2017-2023(USD Million)
FIG. 24 Global IVF market share, by end-use, 2017 & 2025
FIG. 25 Fertility clinics market, 2017-2023(USD Million)
FIG. 26 Hospitals market, 2017-2023(USD Million)
FIG. 27 Regional market place: Key takeaways
FIG. 28 Regional outlook, 2017 & 2025
FIG. 29 North America IVF service market, 2017-2023(USD Million)
FIG. 30 North America IVF device market, 2017-2023(USD Million)
FIG. 31 U.S. IVF service market, 2017-2023(USD Million)
FIG. 32 U.S. IVF device market, 2017-2023(USD Million)
FIG. 33 Canada IVF service market, 2017-2023(USD Million)
FIG. 34 Canada IVF device market, 2017-2023(USD Million)
FIG. 35 Europe IVF service market, 2017-2023(USD Million)
FIG. 36 Europe IVF device market, 2017-2023(USD Million)
FIG. 37 UK IVF service market, 2017-2023(USD Million)
FIG. 38 UK IVF device market, 2017-2023(USD Million)
FIG. 39 France IVF service market, 2017-2023(USD Million)
FIG. 40 France IVF device market, 2017-2023(USD Million)
FIG. 41 Germany IVF service market, 2017-2023(USD Million)
FIG. 42 Germany IVF device market, 2017-2023(USD Million)
FIG. 43 Asia Pacific IVF service market, 2017-2023(USD Million)
FIG. 44 Asia Pacific IVF device market, 2017-2023(USD Million)
FIG. 45 India IVF service market, 2017-2023(USD Million)
FIG. 46 India IVF device market, 2017-2023(USD Million)
FIG. 47 China IVF service market, 2017-2023(USD Million)
FIG. 48 China IVF device market, 2017-2023(USD Million)
FIG. 49 Japan IVF service market, 2017-2023(USD Million)
FIG. 50 Japan IVF device market, 2017-2023(USD Million)
FIG. 51 Latin America IVF service market, 2017-2023(USD Million)
FIG. 52 Latin America IVF device market, 2017-2023(USD Million)
FIG. 53 Brazil IVF service market, 2017-2023(USD Million)
FIG. 54 Brazil IVF device market, 2017-2023(USD Million)
FIG. 55 Mexico IVF service market, 2017-2023(USD Million)
FIG. 56 Mexico IVF device market, 2017-2023(USD Million)
FIG. 57 MEA IVF service market, 2017-2023(USD Million)
FIG. 58 MEA IVF device market, 2017-2023(USD Million)
FIG. 59 South Africa IVF service market, 2017-2023(USD Million)
FIG. 60 South Africa IVF device market, 2017-2023(USD Million)

 

Summary

No Content Available.

PURCHASE OPTIONS

ASK FOR SPECIAL PRICING

Related Reports